Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

Cicin, IrfanGumus, MahmutUncu, DoganOzkan, MetinKilickap, SaadettinElkiran, Tamer E.Isikdogan, Abdurrahman2024-06-122024-06-1220170732-183X1527-7755https://doi.org/10.1200/JCO.2017.35.15_suppl.e15055https://hdl.handle.net/20.500.14551/2593253rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, IL[Abstract Not Available]en10.1200/JCO.2017.35.15_suppl.e15055info:eu-repo/semantics/closedAccess[No Keywords]Characteristics of Turkish colorectal cancer patients and bevacizumab preference.Conference Object35Q1WOS:000411895707157